Ma et al. identified 75 components from Scutellaria barbata extract using high-performance liquid chromatography and predicted through a “drug-component-target-pathway” model that the Scutellaria barbata and Hedyotis diffusa combination exerts anti-tumor effects by inhibiting the PI3K/AKT pathway. Here, PIK3CA is linked to neoplasm.